纵横研报
Ticker Detail

600062.SHG

¥17.25+2.31% 华润双鹤 Drug Manufacturers - Specialty & Generic
00Reports China 医疗健康
China Resources Double-Crane Pharmaceutical Co Ltd
医疗健康 · 专科与仿制药

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People's Republic of China. The company offers pharmaceutical products for blood pressure and sugar, injections, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, psychiatry/neurology, inflammation, anticoagulation, oncology, women's health, anesthesia, and analgesia. The company was founded in 1939 and is headquartered in Beijing, the People's Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a subsidiary of Beijing Pharmaceutical Group Co., Ltd.

MARKET 市值 17.21B CNY PE 10.6x Fwd 12.3x 52W ¥15.29 – ¥22.14 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY -8.8% ROE 13.5% 营业利润率 19.9% 净利润率 15.2%
ANALYST 股息率 2.92%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制